Abstract:Regulatory T cells (Tregs) are essential to maintain immune homeostasis by promoting self-tolerance. Reduced Treg numbers or functionality can lead to a loss of tolerance, increasing the risk of developing autoimmune diseases. An overwhelming variety of human Tregs has been described, based on either specific phenotype, tissue compartment, or pathological condition, yet the bulk of the literature only addresses CD25-positive and CD127-negative cells, coined by naturally occurring Tregs (nTregs), most of which express the transcription factor Forkhead box protein 3 (FOXP3). While the discovery of FOXP3 was seminal to understanding the origin and biology of nTregs, there is evidence in humans that not all T cells expressing FOXP3 are regulatory, and that not all Tregs express FOXP3. Namely, the activation of human T cells induces the transient expression of FOXP3, irrespective of whether they are regulatory or inflammatory effectors, while some induced T cells that may be broadly defined as Tregs (e.g., Tr1 cells) typically lack demethylation and do not express FOXP3. Furthermore, it is unknown whether and how many nTregs exist without FOXP3 expression. Several other candidate regulatory molecules, such as GITR, Lag-3, GARP, GPA33, Helios, and Neuropilin, have been identified but subsequently discarded as Treg-specific markers. Multiparametric analyses have uncovered a plethora of Treg phenotypes, and neither single markers nor combinations thereof can define all and only Tregs. To date, only the functional capacity to inhibit immune responses defines a Treg and distinguishes Tregs from inflammatory T cells (Teffs) in humans. This review revisits current knowledge of the Treg universe with respect to their heterogeneity in phenotype and function. We propose that it is unavoidable to characterize human Tregs by their phenotype in combination with their function, since phenotype alone does not unambiguously define Tregs. There is an unmet need to align the expression of specific markers or combinations thereof with a particular suppressive function to coin functional Treg entities and categorize Treg diversity.

Regulatory T Cells: the Many Faces of Foxp3

Regulatory T Cells: Regulation of Identity and Function

FoxP3 in T<sub>reg</sub> cell biology: a molecular and structural perspective

FoxP3 in Treg Cell Biology: a Molecular and Structural Perspective

Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations

FoxP3 in T reg cell biology: a molecular and structural perspective

Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

Tregs: Where We Are and What Comes Next?

Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity

Foxp3+ Regulatory T Cells: a Protagonist in the “movie’’ of Autoimmune Diseases?

Foxp3 Post-translational Modifications and Treg Suppressive Activity

Transcriptional regulation of Foxp3 in regulatory T cells

Deciphering the developmental trajectory of tissue-resident Foxp3+ regulatory T cells

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

Foxp3, Regulatory T Cell, and Autoimmune Diseases

The regulation of immune tolerance by FOXP3

Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation

Functional reprogramming of regulatory T cells in the absence of Foxp3

Pathological Conditions Re-Shape Physiological Tregs into Pathological Tregs